Zepp Health Corp (ZEPP) Form 6-K — Jun 9, 2026
Zepp Health reported Q1 2026 revenue of $51.5 million, a 33.8% year-over-year increase, driven by new product launches including the Active Max and T-Rex Ultra 2. This growth exceeded expectations for the traditionally soft first quarter in consumer electronics, with gross margin expanding to 37.7% from 37.3% in the prior year. The company posted a GAAP net loss of $19.6 million, a slight improvement from the $19.7 million loss in Q1 2025, while adjusted operating loss narrowed to $16.3 million from $17.2 million.
Key figures
- Revenue
- 51547000
- Guidance
- Q2 2026 revenue expected between $63.0 million and $68.0 million
- Revenue Yoy
- 33.8%
- Gross Profit
- 19437000
- Inventory
- 62839000
- Rd Expenses
- 13134000
- Gross Margin
- 37.7%
- Ga And AExpenses
- 7355000
- Shares Repurchased
- 2300000
- Repurchase Value Used
- 17000000
- Debt Retired Since2023
- 46400000
- Selling Marketing Expenses
- 16640000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.